Clinical Trials Sponsored by Ayşegül Akca
Total 68 results
-
Ayşegül AkcaCompletedProfessional Values | Ethical SensitivitiesTurkey
-
Ayşegül AkcaThe Scientific and Technological Research Council of TurkeyCompleted
-
ayşegül musluCompletedGynecology | Gynecology/Obstetrics ConditionsTurkey
-
Ayşegül BOSTANCompleted
-
Ayşegül İşler DalgıçHorizonNot yet recruitingStress, Emotional | Health Risk Behaviors | Health-Related Behavior | Healthy Lifestyle | Physical Inactivity | Healthy Nutrition | Healthy Eating Index | Non Communicable DiseasesTurkey
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
Akcea TherapeuticsRecruitingPregnancy | Hereditary Transthyretin-mediated Amyloidosis With PolyneropathyUnited States
-
Akcea TherapeuticsCompletedCardiovascular Diseases | Elevated Lipoprotein(a)Canada
-
Akcea TherapeuticsCompletedCardiovascular Diseases | Elevated Lipoprotein(a)Canada
-
ARCA Biopharma, Inc.CompletedCatheters, IndwellingUnited States
-
ARCA Biopharma, Inc.SuspendedColon CancerUnited States
-
ARCA Biopharma, Inc.TerminatedAcute Ischemic StrokeUnited States, Canada
-
ARCA Biopharma, Inc.CompletedArterial Occlusive DiseasesUnited States
-
Ankara UniversityBengi Safak; Ahmet Onat Bermede; Ayşegül GüvenCompletedCatheterization | CannulationTurkey
-
ARCA Biopharma, Inc.CompletedThrombosis | Venous Thrombosis | Catheter OcclusionUnited States
-
ARCA Biopharma, Inc.CompletedThrombosis | Venous ThrombosisUnited States
-
ARCA Biopharma, Inc.Unknown
-
ARCA Biopharma, Inc.TerminatedArterial Occlusive DiseasesUnited States
-
Akcea TherapeuticsCaligorRx, Inc.No longer availableFamilial Chylomicronemia
-
Bursa City HospitalNermin Kelebek Girgin; Ayşegül Özkan; Gülbahar ÇalışkanRecruitingInflammation | Intensive Care Unit | Nutritional DeficiencyTurkey
-
ARCA Biopharma, Inc.MedtronicCompletedCurrent or Recent History of Atrial FibrillationUnited States, Canada, Hungary, Netherlands, Poland, Serbia
-
Kıvanç AkçaHacettepe UniversityCompleted
-
Kıvanç AkçaHacettepe UniversityCompletedCementation (MeSH Unique ID: D002484) | Dental Implant-Abutment Design (MeSH Unique ID: D059605) | Crown (MeSH Unique ID: D003442) Surfaces | Contour: Crown (MeSH Unique ID: D003442) - Dental Implant (MeSH Unique ID: D015921) AbutmentTurkey
-
Aysegul KilicliRecruiting
-
Aysegul KilicliRecruitingPreeclampsia | Mindfulness Breath Awareness MeditationTurkey
-
Aysegul KilicliRecruitingNEUROLINGUISTIC PROGRAMMING | PROGRESSIVE MUSCLE RELAXATION EXERCISES | CAESAREAN SECTIONTurkey
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Brazil, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, South Africa, Spain, United Kingdom
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Disease | Elevated Lipoprotein(a)United States, Canada, Denmark, Germany, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedRenal ImpairmentUnited States, Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompleted
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.WithdrawnHomozygous Familial HypercholesterolemiaCanada
-
Aysegul KilicliRecruiting
-
Aysegul CelikEnrolling by invitation
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Israel, Spain, Italy, United Kingdom, Netherlands, Canada, Hungary, Sweden, France, Norway, Portugal, Slovakia
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Diseases | HypertriglyceridemiaUnited States, Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedAbnormalities, CardiovascularUnited States
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedElevated Triglycerides (TG)Canada
-
Akcea TherapeuticsUnited BioSource, LLCRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, France, Greece, Italy, Spain, Canada, Germany, Portugal
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemiaUnited States, Canada, France, Germany, United Kingdom, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.TerminatedFamilial Partial LipodystrophyUnited States, Netherlands, Belgium, Brazil, Canada, Germany, Russian Federation
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Partial LipodystrophyUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemia | Familial HypercholesterolemiaCanada
-
Ayca Solt KircaCompleted
-
ARCA Biopharma, Inc.Health DecisionsCompletedArterial Occlusive Diseases | Thrombosis | Peripheral Vascular DiseasesUnited States
-
Aysegul DurmazCompletedBehavior | PerceptionsTurkey
-
Aysegul DurmazCompletedThe Impact of Breastfeeding Education on Breastfeeding Behavior and the Use of Traditional PracticesBreastfeeding | Post Procedural Discharge | Breasfeeding Traditional PracticesTurkey